Diagnosis of hepatic iron overload;Diagnostic d'une surcharge hépatique en fer

Revue de Medecine Interne

Volumn 33, Issue SUPPL. 1, 2012, Pages

  Deugnier, Y ^a,b,c,d   Bardou Jacquet, E ^a,b,c,d   Laine F ^a,b,d   Gandon, Y ^b,c,d   Jouanolle, A M ^b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d INSERM   (France)

Author keywords

Hemochromatosis; Hepatic iron overload; Metabolic syndrome

Indexed keywords

ARTICLE; IRON OVERLOAD; LIVER DISEASE;

DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; HUMANS; INTERNAL MEDICINE; IRON OVERLOAD; LIVER; LIVER DISEASES; SEVERITY OF ILLNESS INDEX;

EID: 84861226066     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2012.03.007     Document Type: Article

References (20)

1. Gandon Y., Olivie D., Guyader D., Aubé C., Oberti F., Sebille V., et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004, 363:357-362.
2. Deugnier Y., Turlin B. Pathology of hepatic iron overload. Semin Liver Dis 2011, 31:260-271.
3. Knisely A.S., Gelbart T., Beutler E. Molecular characterization of a third case of human atransferrinemia. Blood 2004, 104:2607.
4. Iolascon A., Camaschella C., Pospisilova D., Piscopo C., Tchernia G., Beaumont C. Natural history of recessive inheritance of DMT1 mutations. J Pediatr 2008, 152:136-139.
5. Deugnier Y., Turlin B., le Quilleuc D., Moirand R., Loréal O., Messner M., et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol 1997, 21:669-675.
6. Detivaud L., Nemeth E., Boudjema K., Turlin B., Troadec M.B., Leroyer P., et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood 2005, 106:746-748.
7. Deugnier Y., Mosser J. Modifying factors of the HFE hemochromatosis phenotype. Expert Rev Gastroenterol Hepatol 2008, 2:531-540.
8. Island M.L., Jouanolle A.M., Mosser A., Deugnier Y., David V., Brissot P., et al. A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis. Haematologica 2009, 94:720-724.
9. Walsh A., Dixon J.L., Ramm G.A., Hewett D.G., Lincold D.J., Anderson G.J., et al. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Clin Gastroenterol Hepatol 2006, 4:1403-1410.
10. Aguilar-Martinez P., Grandchamp B., Cunat S., Cadet E., Blanc F., Nourrit M., et al. Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants. Haematologica 2011, 96:507-514.
11. Roetto A., Papanikolaou G., Politou M., Alberti F., Girelli D., Christakis J., et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003, 33:21-22.
12. Papanikolaou G., Samuels M.E., Ludwig E.H., Mc Donald M.L., Franchini P.L., Dubé M.P., et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004, 36:77-82.
13. Camaschella C., Roetto A., Cali A., De Gobbi M., Garozzo G., Carella M., et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000, 25:14-15.
14. Mendler M.H., Turlin B., Moirand R., Jouanolle A.M., Sapey T., Guyader D., et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999, 117:1155-1163.
15. Turlin B., Mendler M.H., Moirand R., Guyader D., Guillygomarc'h A., Deugnier Y. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients. Am J Clin Pathol 2001, 116:263-270.
16. Ruivard M., Laine F., Ganz T., Olbina G., Wesdterman M., Nemeth E., et al. Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin. J Hepatol 2009, 50:1219-1225.
17. Le Lan C., Mosser A., Ropert M. Biochemical features but not genotypes associated with phenotypes of ferroportin disease. Gastroenterology 2011, 140:1199-1207.
18. McNeill A., Pandolfo M., Kuhn J., Shang H., Miyajima H. The neurological presentation of ceruloplasmin gene mutations. Eur Neurol 2008, 60:200-205.
19. Guyader D., Jacquelinet C., Moirand R., Turlin B., Mendler M.H., Chaperon J., et al. Non-invasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998, 115:929-936.
20. Crawford D.H., Murphy T.L., Ramm L.E., Fletcher L.M., Clouston A.D., Anderson G.J., et al. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. Hepatology 2009, 49:418-425.